EUCTR2005-003770-23-AT进行中（未招募）不适用
Comparative Trial inMultiple Myeloma Patients of Oral Ibandronic Acid versus Intravenous Zoledronate: a phase III study
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 424
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with multiple myeloma & confirmation of bone lesions
- •Age > 18 years
- •Patient’s written informed consent
- •WHO performance status 0-2
- •Life expectancy of ? 6 months
- •Adequate renal function (defined by a creatinine clearance >60 ml/min)
- •No history of brain metastases
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any circumstance liable to compromise follow-up and compliance
- •Pregnant or lactating period
- •Participation in a clinical trial with any investigational drug within 4 weeks preceding the first dose of the study drug
- •History of other concomitant cancer in evolution
- •Prior bisphosphonate treatment with the exception of bisphosphonate treatment for hypercalcemia and osteoporosis
- •Pre-scheduled radiotherapy that would fall within the study period
研究者
相似试验
进行中（未招募）
不适用
Randomised comparisons, in myeloma patients of all ages, of thalidomide, lenalidomide, carfilzomib and bortezomib induction combinations, and of lenalidomide and combination lenalidomide vorinostat as maintenance - Myeloma XIewly diagnosed patients with symptomatic myelomaMedDRA version: 16.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2009-010956-93-GBniversity of Leeds4,000
已完成
不适用
The GMMG-HD5 trial: bortezomib-based induction prior to high dose therapy and autologous stem cell transplantation followed by lenalidomide-based consolidation and maintenance therapy in patients with multiple myelomaCancerMultiple myelomaISRCTN05745813Heidelberg University (Germany)504
已完成
不适用
Study of the outcome of patients with myeloma nephropathy on treatment with High Cut Off Haemodialysis (HCO-HD) in addition to chemotherapy at the Launceston General HospitalBlood - Haematological diseasesMultiple MyelomaACTRN12612000024842Clifford Craig Medical Trust Fund10
进行中（未招募）
不适用
Is a PET/MRI scan better than a PET/CT scan at visualising bone lesions and their change with treatment in adults with myeloma?CancerISRCTN15606951King's College London20
尚未招募
Unknown
ovel Combinations for Orphan Myeloma: The NORM Platform StudyKCT0008451Samsung Medical Center140